eTAG assay predict treatment outcomes for colorectal cancer
This article was originally published in Clinica
Executive Summary
A Canadian pilot study assessing the ability of ViroLogic's eTAG assays to predict treatment outcomes for patients with metastatic colorectal cancer has produced positive results.